🔎 Trials Near Me

Home › Von Hippel-Lindau Disease

Von Hippel-Lindau Disease clinical trials recruiting in the U.S.

7 studies for Von Hippel-Lindau Disease are recruiting participants at sites across the United States.

Von Hippel-Lindau disease (VHL) is a rare, genetic disease that causes tumors and cysts to grow in your body.

Cities with the most studies

By state

Recently updated studies

National Eye Institute Biorepository for Retinal Diseases

RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 120 · All sexes · Updated Sep 28, 2026 · NCT01496625

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07405164

Data Collection Protocol for Patients With Von Hippel Lindau Disease

RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT05955014

Familial Investigations of Childhood Cancer Predisposition

RecruitingObservational study
All ages · All sexes · Updated Jun 17, 2026 · NCT03050268

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

RecruitingPhase 2
Ages 12 and older · All sexes · Updated Apr 20, 2026 · NCT04074135

MyVHL: Patient Natural History Study

RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Apr 26, 2024 · NCT03749980

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.